V. Ninane (Brussels, Belgium), A. Rozman (Golnik, Slovenia), C. Brambilla (Grenoble, France), A. Kempa (Stuttgart, Germany)
Detection of early stage lung cancer by electronic nose
M. Bukovskis, G. Strazda, N. Jurka, U. Kopeika, A. Pirtnieks, L. Balode, J. Aprinceva, I. Kantane, I. Taivans (Riga, Latvia)
|   |
Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by multifactorial logistic regression analysis
M. Bukovskis, G. Strazda, N. Jurka, U. Kopeika, A. Pirtnieks, L. Balode, J. Aprinceva, I. Kantane, I. Taivans (Riga, Latvia)
| |
Proteomics and screening of lung cancer: Biomarkers selection by mass spectrometry and ELISA in the exhaled breath condensate (EBC)
C. Montero-Martínez, L. Núñez-Naveira, L. A. Mariñas-Pardo (A Coruña, Spain)
| |
Analysis of exhaled breath with electronic nose and discrimination of lung cancer and COPD by logistic regression analysis
G. Strazda, M. Bukovskis, U. Kopeika, A. Pirtnieks, N. Jurka, L. Balode, J. Aprinceva, A. Kislina, V. Silins, I. Taivans (Riga, Latvia)
| |
Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD
M. A. Munoz-Lucas, C. Wagner-Struwing, J. Jareno-Esteban, J. de Miguel-Diez, B. Carrillo-Aranda, C. Gutierrez-Ortega, C. Civera-Tejuca, L. Callol-Sanchez (Madrid, Spain)
| |
Significance of imaging-related and other factors as predictors of survival time in non small cell lung cancer
A. Kumar, H. H. Thygesen, A. Scarsbrook (Leeds, United Kingdom)
| |
The role of magnetic resonance imaging in staging of NSCLC
A. Reshetov, N. Mitrifanov, V. Klimenko, O. Kakisheva, A. Elkin (Saint-Peterburg, Saint-Petersburg, Russian Federation)
| |
Impact of PET scan on staging and management of lung cancer patients in Indian scenario
K. Modi, J. Joshi (Mumbai, India)
| |
A survey of outcome of CT guided lung biopsies in a tertiary centre
R. Sarkar, H. Saleem, S. Hussain, A. Wight, W. Kent, C. Irion, M. Ledson (Liverpool, United Kingdom)
| |
TNF-alpha, IL-1 and IL-6 concentration in bronchoalveolar lavage fluid (BALF) of non-small cell lung cancer (NSCLC)
M. Petrovic, I. Cekerevac, V. Cupurdija, V. Zdravkovic, R. Vucic (Kragujevac, Republic Of Serbia)
| |
Matrix metalloproteinase-9 (MMP-9) elevated in serum, but not in bronchial lavage in lung cancer patients
M. Koç, D. Ediger, F. Budak, M. Karadag, B. Oral, E. Uzaslan, E. Ege, O. Gözü (Bursa, Turkey)
| |
The value of obtaining brushing samples in addition to biopsy and washings in the diagnosis of lung cancer
S. Tariq, T. Howes (Colchester, United Kingdom)
| |
Noninvasive detection of EGFR T790M mutation in gefitinib resistant non-small cell lung cancer using mutant-enriched PCR
C. He, L. Zheng, Y. Xu, M. Liu, Y. Li, J. Xu (Shenzhen, Guangzhou, China)
| |
Role of Dr-70 immunoassay in suspected malignant pleural effusion
D. Jash, K. Saha, A. Sengupta, S. N. Bannerjee, D. Jash (Kolkata, India)
| |
Changes in oxidative stress parameters and antioxidant status in lung cancer: Western blot analysis of nitrotyrosine and protein carbonyls content
G. G. Korkmaz, B. B. Inal, G. M. Ortakoylu, H. Irmak, A. A. Kara, R. Gelisgen, O. Ogurlu, H. Uzun (Kirklareli, Istanbul, Turkey)
| |
Diagnosis of pathological changes in bronchial tree using focal fluorescence spectroscopy
N. Poliakova, O. Cheremisina, N. Bulgakova (Tomsk, Moscow, Russian Federation)
| |
How effective was broncoscopic biopsy during 2011 in Albania?
D. Xhemalaj, G. Cerga, G. Cekodhima, J. Nikolla, L. Berdica (Tirana, Albania)
| |
Correlation of FDG-PET/CT and EBUS-TBNA for nodal staging in lung cancer
P. Hoffknecht, M. Enderle, G. May, H. Schubert, S. Rüther, S. Fischer, P. Zardo, N. J. Dickgreber (Rheine, Ibbenbüren, Germany)
| |
Vascular pattern assessment of bronchial lesions with narrow-band imaging bronchoscopy
A. Strunina, R. Kuvaev, S. Kashin, A. Nadezhin (Yaroslavl, Russian Federation)
| |